MARKHAM, ON, July 12, 2018 /CNW/ - MedReleaf
Corp. (TSX:LEAF) ("MedReleaf" or the "Company"), today
announced that it has entered into a Memorandum of Understanding
("MOU") with the British Columbia Liquor Distribution Branch
("BCLDB") to supply the Province with high quality adult
recreational-use cannabis products.
Under the terms of the MOU, MedReleaf has agreed
to supply the BCLDB with cannabis products in a variety of
formats including dried flower and capsules. MedReleaf will be
represented on British Columbia's
on-line and brick and mortar retail outlets under the
San Rafael '71, AltaVie and Woodstock brands.
San Rafael '71 is inspired by and designed to
celebrate the spirit of classic cannabis culture, aimed at
discerning adults who are knowledgeable about cannabis
products and who value quality and an authentic experience.
AltaVie is designed for a premium consumer and those
new to cannabis who are curious, selective and interested in
general wellness and enrichment. Woodstock is an iconic brand and a
trusted symbol of the lifestyles of the cannabis community;
bringing to market quality products that embody the values
of Woodstock.
"Partnering with the BC Liquor Distribution Branch in
supplying adult recreational cannabis is a valuable opportunity for
MedReleaf to expand our footprint across Canada," said Neil Closner, CEO
of MedReleaf. "With an annual production capacity that will
approach 140,000 kilograms, we are well equipped to meet the
anticipated high demand that discerning BC consumers will have for
the premium quality cannabis products that MedReleaf has become
recognized for across Canada."
As Canada's leading supplier of premium medical
and recreational cannabis, MedReleaf is recognized for
its commitment to cultivating consistent, safe, high-quality
cannabis. That same exceptional quality is applied to the
cultivation and production of all recreational cannabis products.
At the voter-driven 2017 Lift Canadian Cannabis
Awards, MedReleaf led the industry by winning LP of the
year and placing in 10 different categories including first place
awards in several product categories: Top Indica Flower, Top CBD
Flower, Top High THC Flower, and Top High CBD Oil.
About MedReleaf Corp.
Canada's most
awarded licensed producer, MedReleaf is an R&D-driven
company dedicated to innovation, operational excellence and the
production of top-quality cannabis. Sourced from around the
world and carefully cultivated in one of two state-of-the-art
ICH-GMP and ISO 9001 certified facilities in Ontario Canada,
with a third facility currently in development,
premium MedReleaf products are delivered to the global
medical market. MedReleaf serves the therapeutic needs of
patients seeking safe, consistent and effective medical cannabis
and provides a compelling product offering for the adult-use
recreational consumer.
For more information on MedReleaf, its products,
research and how the company is helping patients #livefree, please
visit MedReleaf.com or follow @medreleaf
SOURCE MedReleaf Corp.